Christophe Hézode

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

Jean-Michel Pawlotsky, Geoffrey Dusheiko, Tara L. Kieffer, 2009, The New England journal of medicine.

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection.

Ronald Pruitt, Stefan Zeuzem, Dominique Thabut, 2016, Journal of hepatology.

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.

Ulysses Diva, Vinod K Rustgi, P. Thuluvath, 2012, The Lancet. Infectious diseases.

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure

Chih-Wei Lin, Joel Gallant, M. Buti, 2018, Hepatology.

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

Riina Salupere, Stefan Zeuzem, Robert Flisiak, 2014, The New England journal of medicine.

Antiviral strategies in hepatitis C virus infection.

Jean-Michel Pawlotsky, Christoph Sarrazin, Stefan Zeuzem, 2012, Journal of hepatology.